Indication
Follicular lymphoma
Follicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts. Read more about Follicular lymphoma
337 drugs 182 manufacturers
Drugs that treat it
Common Follicular lymphoma therapies.
METHYLPREDNISOLONE
METHYLPREDNISOLONE
DEXPAK (dexamethasone)
ZEVALIN (kit for prep yttrium-90/ibritumomab tiuxetan/albumin human)
ADRIAMYCIN (doxorubicin HCl)
ADRIAMYCIN (doxorubicin HCl)
DEXPAK (dexamethasone)
BENDAMUSTINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonFollicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts.
It predominantly affects older adults and involves the lymphatic and hematopoietic systems, commonly presenting with painless, generalized lymphadenopathy, frequent bone marrow infiltration, and splenomegaly.
Pathophysiologically, it is defined by a nodular or follicular growth pattern and hallmark genetic alterations, most notably the t(14;18)(q32;q21) chromosomal translocation that juxtaposes the *BCL2* oncogene with the immunoglobulin heavy chain locus, leading to constitutive BCL-2 overexpression and inhibition of apoptosis.
While typically characterized by a prolonged, relapsing-and-remitting course, the disease carries an ongoing risk of histologic transformation into aggressive diffuse large B-cell lymphoma.
- cancer.gov
Follicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts Pathophysiologically, it is defined by a nodular or follicular growth pattern and hallmark genetic alterations, most notably the t(14;18)(q32;q21) chromosomal translocation that juxtaposes the *BCL2* oncogene with the immunoglobulin heavy chain locus, leading to constitutive BCL-2 overexpression and inhibition of apoptosis
- nih.gov
Follicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts It predominantly affects older adults and involves the lymphatic and hematopoietic systems, commonly presenting with painless, generalized lymphadenopathy, frequent bone marrow infiltration, and splenomegaly While typically characterized by a prolonged, relapsing-and-remitting course, the disease carries an ongoing risk of histologic transform...
- nih.gov
Follicular lymphoma is a typically indolent B-cell non-Hodgkin lymphoma arising from germinal center B lymphocytes, primarily centrocytes and centroblasts It predominantly affects older adults and involves the lymphatic and hematopoietic systems, commonly presenting with painless, generalized lymphadenopathy, frequent bone marrow infiltration, and splenomegaly While typically characterized by a prolonged, relapsing-and-remitting course, the disease carries an ongoing risk of histologic transform...
- nih.gov
Pathophysiologically, it is defined by a nodular or follicular growth pattern and hallmark genetic alterations, most notably the t(14;18)(q32;q21) chromosomal translocation that juxtaposes the *BCL2* oncogene with the immunoglobulin heavy chain locus, leading to constitutive BCL-2 overexpression and inhibition of apoptosis
Personalize your experience
Follow Follicular lymphoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.